Literature DB >> 26109207

Mild Chronic Hyponatremia in the Ambulatory Setting: Significance and Management.

Helbert Rondon-Berrios1, Tomas Berl2.   

Abstract

Mild chronic hyponatremia, as defined by a persistent (>72 hours) plasma sodium concentration between 125 and 135 mEq/L without apparent symptoms, is common in ambulatory patients and generally perceived as being inconsequential. The association between increased mortality and hyponatremia in hospitalized patients in various settings and etiologies is widely recognized. This review analyzes the significance of mild chronic hyponatremia in ambulatory subjects and its effects on mortality and morbidity. It addresses whether this disorder should even be treated and if so, which patients are likely to benefit from treatment. The available approaches to correct hyponatremia in such patients in the context of recently published panel-generated recommendations and guidelines are described.
Copyright © 2015 by the American Society of Nephrology.

Entities:  

Keywords:  hyponatremia; morbidity; mortality; tolvaptan; urea

Mesh:

Substances:

Year:  2015        PMID: 26109207      PMCID: PMC4670756          DOI: 10.2215/CJN.00170115

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  76 in total

Review 1.  Vasopressin receptor antagonists for the treatment of hyponatremia: systematic review and meta-analysis.

Authors:  Benaya Rozen-Zvi; Dafna Yahav; Mihai Gheorghiade; Asher Korzets; Leonard Leibovici; Uzi Gafter
Journal:  Am J Kidney Dis       Date:  2010-06-09       Impact factor: 8.860

Review 2.  Brain volume regulation in response to changes in osmolality.

Authors:  J G Verbalis
Journal:  Neuroscience       Date:  2010-04-24       Impact factor: 3.590

3.  Treatment of the syndrome of inappropriate secretion of antidiuretic hormone with urea in critically ill patients.

Authors:  Julien Coussement; Christine Danguy; Karim Zouaoui-Boudjeltia; Pierre Defrance; Lise Bankir; Patrick Biston; Michael Piagnerelli
Journal:  Am J Nephrol       Date:  2012-02-23       Impact factor: 3.754

4.  Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry.

Authors:  Mihai Gheorghiade; William T Abraham; Nancy M Albert; Wendy Gattis Stough; Barry H Greenberg; Christopher M O'Connor; Lilin She; Clyde W Yancy; James Young; Gregg C Fonarow
Journal:  Eur Heart J       Date:  2007-02-19       Impact factor: 29.983

5.  Mild hyponatremia as a risk factor for fractures: the Rotterdam Study.

Authors:  Ewout J Hoorn; Fernando Rivadeneira; Joyce B J van Meurs; Gijsbertus Ziere; Bruno H Ch Stricker; Albert Hofman; Huibert A P Pols; Robert Zietse; André G Uitterlinden; M Carola Zillikens
Journal:  J Bone Miner Res       Date:  2011-08       Impact factor: 6.741

Review 6.  Is asymptomatic hyponatremia really asymptomatic?

Authors:  Guy Decaux
Journal:  Am J Med       Date:  2006-07       Impact factor: 4.965

7.  Hyponatremia independent of osteoporosis is associated with fracture occurrence.

Authors:  Sinead Kinsella; Sarah Moran; Miriam O Sullivan; Michael G M Molloy; Joseph A Eustace
Journal:  Clin J Am Soc Nephrol       Date:  2010-01-07       Impact factor: 8.237

8.  Mild hyponatremia and risk of fracture in the ambulatory elderly.

Authors:  F Gankam Kengne; C Andres; L Sattar; C Melot; G Decaux
Journal:  QJM       Date:  2008-05-13

9.  Superiority of demeclocycline over lithium in the treatment of chronic syndrome of inappropriate secretion of antidiuretic hormone.

Authors:  J N Forrest; M Cox; C Hong; G Morrison; M Bia; I Singer
Journal:  N Engl J Med       Date:  1978-01-26       Impact factor: 91.245

10.  Treatment of euvolemic hyponatremia in the intensive care unit by urea.

Authors:  Guy Decaux; Caroline Andres; Fabrice Gankam Kengne; Alain Soupart
Journal:  Crit Care       Date:  2010-10-14       Impact factor: 9.097

View more
  13 in total

1.  Hyponatremia in solid-tumor cancer patients: uncertainty regarding the use of vaptans.

Authors:  François Vincent; Soufia Ayed; Abdelaziz Bouguerba; Dany Goldgran-Toledano; Caroline Bornstain
Journal:  Support Care Cancer       Date:  2016-03-17       Impact factor: 3.603

2.  Prevalence of hyponatremia in inpatients with incurable and life-limiting diseases and its association with physical symptoms-a retrospective descriptive study.

Authors:  Kerstin Kremeike; Ricarda M L Wetter; Volker Burst; Raymond Voltz; Kathrin Kuhr; Steffen T Simon
Journal:  Support Care Cancer       Date:  2017-08-18       Impact factor: 3.603

3.  Urea for the Treatment of Hyponatremia.

Authors:  Helbert Rondon-Berrios; Srijan Tandukar; Maria K Mor; Evan C Ray; Filitsa H Bender; Thomas R Kleyman; Steven D Weisbord
Journal:  Clin J Am Soc Nephrol       Date:  2018-09-04       Impact factor: 8.237

4.  Assocıatıons between mıld hyponatremıa and gerıatrıc syndromes ın outpatıent settıngs.

Authors:  Cihan Heybeli; Lee Smith; Pinar Soysal
Journal:  Int Urol Nephrol       Date:  2021-02-18       Impact factor: 2.370

Review 5.  Vasopressin Receptor Antagonists in Hyponatremia: Uses and Misuses.

Authors:  Helbert Rondon-Berrios; Tomas Berl
Journal:  Front Med (Lausanne)       Date:  2017-08-21

6.  Omeprazole-induced and pantoprazole-induced asymptomatic hyponatremia: a case report.

Authors:  Isabel J B van der Zalm; Tom J M Tobé; Susan J J Logtenberg
Journal:  J Med Case Rep       Date:  2020-06-29

7.  Symptomatology of carbamazepine- and oxcarbazepine-induced hyponatremia in people with epilepsy.

Authors:  Bianca Berghuis; Janic Hulst; Anja Sonsma; Mark McCormack; Gerrit-Jan de Haan; Josemir W Sander; Dick Lindhout; Bobby P C Koeleman
Journal:  Epilepsia       Date:  2021-02-12       Impact factor: 5.864

Review 8.  Dysnatremias in Chronic Kidney Disease: Pathophysiology, Manifestations, and Treatment.

Authors:  Soraya Arzhan; Susie Q Lew; Todd S Ing; Antonios H Tzamaloukas; Mark L Unruh
Journal:  Front Med (Lausanne)       Date:  2021-12-06

9.  Tolvaptan versus fluid restriction in acutely hospitalised patients with moderate-profound hyponatraemia (TVFR-HypoNa): design and implementation of an open-label randomised trial.

Authors:  Annabelle M Warren; Mathis Grossmann; Rudolf Hoermann; Jeffrey D Zajac; Nicholas Russell
Journal:  Trials       Date:  2022-04-21       Impact factor: 2.728

Review 10.  Issues and Controversies in the Evolution of Oral Rehydration Therapy (ORT).

Authors:  David Nalin
Journal:  Trop Med Infect Dis       Date:  2021-03-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.